IPO Calendar
Lead Manager
- J P Morgan Chase (506)
- Goldman Sachs (485)
- Morgan Stanley (443)
- Bank of America Merrill Lynch (368)
- Citigroup (232)
- Jefferies (222)
- Credit Suisse (180)
- Barclays (156)
- Cowen and Company (147)
- Deutsche Bank (85)
- Leerink Partners (71)
- Piper Jaffray (70)
- Stifel (66)
- UBS Investment Bank (56)
- Evercore (54)
- RBC Capital (52)
- BMO Capital (51)
- Wells Fargo (48)
- Piper Sandler (41)
- Raymond James (39)
More +
IPO - Pricing (41)
Piper Sandler
UnderWriters* | |||||||||||
Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 14 | Sagimet Bioscie | Health Care | 16 | 5 | GS | PS | JMPS | 5.5% | -0.3% | ||
May 5 | Acelyrin, Inc. | Health Care | 18 | 30 | MS | JEFF | PS | 23.3% | 28.6% | ||
Mar 9 | Atlas Energy So | Energy | 18 | 18 | GS | BAML | PS | 33.7% | -7.5% | ||
Mar 26 | Design Therapeu | Health-Care | 20 | 12 | GS | SVB | PS | 4% | 70.1% | ||
Mar 31 | Achilles Therap | Health-Care | 18 | 9 | JPM | BAML | PS | 21.5% | -8.1% | ||
Apr 9 | Reneo Pharmaceu | Health-Care | 15 | 6 | JEFF | SVB | PS | 29.7% | -7% | ||
Apr 16 | Biomea Fusion I | Health-Care | 17 | 9 | JPM | JEFF | PS | 39.9% | 9.4% | ||
Apr 16 | Akoya Bioscienc | Health-Care | 20 | 6 | JPM | MS | PS | 57.8% | 30.3% | ||
Apr 21 | SkyWater Techno | Technology | 14 | 7 | JEFF | COWN | PS | 102.9% | 23.9% | ||
Apr 23 | Rain Therapeuti | Health-Care | 17 | 7 | GS | CITI | PS | 60.1% | -7.1% | ||
May 27 | Day One Biophar | Health-Care | 16 | 10 | JPM | COWN | PS | 19.6% | 61.8% | ||
Jan 13 | Skyward Special | Finance | 15 | 9 | BRCL | KBW | PS | 46.4% | 27.3% | ||
Jun 24 | Monte Rosa Ther | Health-Care | 19 | 11 | JPM | COWN | PS | 33.4% | 11.5% | ||
Jun 30 | CVRx Inc. | Health-Care | 18 | 7 | JPM | PS | WB | 7.9% | 44.8% | ||
Jul 2 | NYXOAH SA | Health-Care | 30 | 2 | PS | Stifel | CNTR | 6.4% | 0.4% | ||
Jul 30 | Tenaya Therapeu | Health-Care | 15 | 12 | MS | COWN | PS | 17.1% | 2.3% | ||
Jul 30 | Omega Therapeut | Health-Care | 17 | 7 | GS | JEFF | PS | 15.8% | -5.9% | ||
Aug 5 | Orange County B | Finance | 33.5 | 1 | PS | STPH | 27.3% | 1.8% | |||
Nov 15 | Acrivon Therape | Health Care | 12.5 | 7 | JEFF | COWN | PS | 7% | 33.1% | ||
Oct 22 | Minerva Surgica | Health-Care | 12 | 6 | JPM | PS | UBS | 56.8% | -25% | ||
Oct 29 | Sonendo Inc. | Health-Care | 12 | 7 | BAML | GS | PS | 41.3% | -23.3% | ||
Oct 29 | Airsculpt Techn | Health-Care | 11 | 7 | MS | PS | SVB | 79.3% | 44.5% | ||
Nov 4 | MDxHEALTH SA | Health-Care | 12 | 3 | PS | OPPN | BTIG | 23.2% | 0% | ||
Nov 9 | Third Coast Ban | Finance | 25 | 3 | STPH | PS | DB | 29.1% | 0% | ||
Nov 19 | FinWise Bancorp | Finance | 10.5 | 3 | PS | 44.6% | 21.2% | ||||
May 13 | ProFrac Holding | Energy | 18 | 16 | JPM | PS | MS | 39.5% | 0.6% | ||
Sep 14 | LINKBANCORP, In | Finance | 7.5 | 4 | STPH | PS | 17.3% | 0.7% | |||
Sep 15 | Corebridge Fina | Finance | 21 | 80 | JPM | MS | PS | 6.2% | -2.4% | ||
Mar 28 | Boundless Bio, | Health Care | 16 | 6 | GS | LRNK | PS | 27.8% | -10.9% | ||
Oct 11 | Camp4 Therapeut | Health Care | 11 | 6 | JPM | LRNK | PS | 12.5% | -2.5% | ||
Oct 11 | UpStream Bio In | Health Care | 17 | 15 | JPM | COWN | PS | 23.8% | 29.4% | ||
Oct 4 | Chain Bridge Ba | Finance | 22 | 1 | PS | RAYJ | HOVD | 18.2% | -3.6% | ||
Sep 11 | LB Pharmaceutic | Health Care | 15 | 19 | LRNK | PS | Stifel | 0% | -100% | ||
Aug 14 | Miami Internati | Finance | 23 | 15 | JPM | MS | PS | 0% | -100% | ||
Aug 8 | Avidbank Holdin | Finance | 23 | 2 | PS | STPH | 0% | -100% | |||
Aug 8 | Heartflow, Inc. | Health Care | 19 | 16 | JPM | MS | PS | 0% | -100% | ||
Jul 31 | Shoulder Innova | Health Care | 15 | 5 | MS | GS | PS | 0% | -100% | ||
Jul 23 | Carlsmed, Inc. | Health Care | 15 | 6 | BAML | GS | PS | 0% | -100% | ||
Jul 2 | CoastalSouth Ba | Finance | 21.5 | 2 | PS | STPH | 0% | -100% | |||
May 5 | American Integr | Finance | 16 | 6 | KBW | PS | WB | 0% | -100% | ||
Mar 6 | Kestra Medical | Health Care | 17 | 11 | BAML | GS | PS | 0% | -100% |
*
Lead manager or one of top three managers in an underwriting team.